In addition, mean levels of serum TMEM166 were significantly lower in the control group (12.54 ± 3.74) than in patients with stroke after CEA (38.01 ± 10.01, p<0.05) (Fig. 1I). The gene discussed is EVA1A; the disease is Stroke.